GI Illness

Feature Article

IDSA Updates Infectious Diarrhea Guidelines

IDSA Updates Infectious Diarrhea Guidelines

The Infectious Diseases Society of America updated its guidelines for the management of acute or persistent infectious diarrhea.

Latest News

FDA Issues Mandatory Recall for Food Products Containing Powdered Kratom

FDA Issues Mandatory Recall for Food Products Containing Powdered Kratom

The agency took this action after Triangle Pharmanaturals LLC failed to cooperate with the FDA's request to conduct a voluntary recall.

H pylori Treatment Tied to Lower Metachronous Gastric Cancer Risk

H pylori Treatment Tied to Lower Metachronous Gastric Cancer Risk

Helicobacter pylori treatment is associated with a reduced rate of metachronous gastric cancer.

FDA: Vancomycin Liquid Oral Treatment Approved for C diff-Associated Diarrhea

FDA: Vancomycin Liquid Oral Treatment Approved for C diff-Associated Diarrhea

Vancomycin is the first liquid oral treatment for C diff-associated diarrhea.

Helicobacter pylori Infection Linked to Gallbladder Diseases

Helicobacter pylori Infection Linked to Gallbladder Diseases

Study aimed to clarify the prevalence of gallbladder diseases, and factors related to gallbladder diseases, and relationships between H pylori infection, gallstones, cholecystitis, and cholecystic polypus.

Delaying Rotavirus Vaccination Until Discharge Leads to Missed Opportunities

Delaying Rotavirus Vaccination Until Discharge Leads to Missed Opportunities

Study found that many hospitalized infants did not receive rotavirus vaccination before discharge and were no longer age-eligible for vaccination after discharge from the hospital.

Raw Flour Linked to Escherichia coli

Raw Flour Linked to Escherichia coli

Raw flour has been linked to E coli infections in 24 states.

Efficacy of Goshuyuto/Rabeprazole for Refractory H pylori

Efficacy of Goshuyuto/Rabeprazole for Refractory H pylori

Refractory Helicobacter pylori infection can be successfully treated with goshuyuto and rabeprazole.

Bezlotoxumab Reduces 30-Day Hospital Readmissions for C difficile Infection

Bezlotoxumab Reduces 30-Day Hospital Readmissions for C difficile Infection

Bezlotoxumab, given with antibacterials for Clostridium difficile, could be effective as a preventive treatment for C difficile infection.

Rotavirus Vaccine Linked to Decrease In Pediatric Gastroenteritis Hospitalizations

Rotavirus Vaccine Linked to Decrease In Pediatric Gastroenteritis Hospitalizations

Implementation of rotavirus vaccination correlated with a reduction in acute gastroenteritis related hospitalization rates among children.

Liver Cancer Mortality Rates Have Doubled Since Mid-1980s

Liver Cancer Mortality Rates Have Doubled Since Mid-1980s

Liver cancer has become the fastest growing cause of cancer deaths in the Unites States.

Sign Up for Free e-newsletters